Delta, Kelowna, BC – August 13, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,
www.potcasts.ca
release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #596, Cannabis News and Stocks on the Move; (NASDAQ: FLGC), (TSX: VLNS), (CSE: COOL), (TSX: HEXO) (NYSE: HEXO)
SHARE PODCAST:
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
The Valens Company Inc. (
TSX: VLNS
) (
OTCQX: VLNCF
)
today announced
the launch of three new products in partnership with Verse Cannabis (“Verse”), including two new vape cartridges and the brand’s first cannabis-infused beverage. With its wide range of products under both the Verse Originals and Verse Concentrates lines, Verse Cannabis now offers products across all categories.
The new products from the Verse Originals line include:
Rapid Tropical Rush
The first cannabis-infused beverage introduced by Verse, Rapid Tropical Rush offers a refreshing twist to classic water with tangy citrus flavours of lemon and lime and a hint of sweet tropical ripe mangoes. Each 250ml stubby bottle is infused with 10 mg of THC and 10 mg of CBD and is equipped with a resealable lid to allow for controlled consumption. Powered by SōRSE by Valens technology, this beverage is free of cannabis taste and smell and offers a quick onset. Rapid Tropical Rush is currently available in Alberta and British Columbia with Ontario to follow in the coming weeks, and a variety of additional beverages are expected to launch from Verse in the coming quarters.
Mango Nectar Vape Cartridge (1g)
The newest flavour addition to the top-selling line of vape cartridges from Verse, this high-potency vape cartridge offers a unique terpene-rich blend of fruity and distinctively sweet mango flavours inspired by the popular Mango Haze strain. Formulated using Valens’ proprietary, ultra-refined extraction processes, the Mango Nectar vape cartridge is comprised of ultra-pure distillate. The cartridge also comes in several other flavours, including Tropic Lemon, Sunset Peach, Mandarin Mint, and Summer Berry, all available in participating Canadian markets, with Mango Nectar currently available in Alberta and arriving in Ontario in the coming weeks.
Verse has also launched a new addition to the Live Terp series under the Verse Concentrates line, the Live Terp Guava x BC Blueberry 510 Vape Cartridge (1g), now available in Alberta and soon to be available in British Columbia and Ontario. This Indica dominant cartridge packs in strong punches of citrus and sour blueberry that develops into a gassy pine finish. Using CO2 extraction, the complete terpene-rich profile of fresh-frozen whole flower is removed, and extracted live terpenes are then added to a highly refined distillate for a smooth, rich pull. The Live Terp Guava x BC Blueberry Vape Cartridge follows the introduction of the Killer Kush Live Terp Vape Cartridge released earlier this summer, available in participating Canadian markets.
Core One Labs Inc. (
CSE: COOL
), (
OTC: CLABD
), a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy,
announced
that its wholly owned subsidiaries, Rejuva Mental Health Clinic and Bluejay Mental Health Group Inc., have partnered to assist their patient with completing an application for exemption under section 56(1) of the Controlled Drugs and Substances Act of Canada for the purpose of legally accessing psilocybin for psychedelic-assisted therapy.
In Canada, psychedelics are classified as controlled substances under the CDSA, and are prohibited for all use, unless a successful application for exemption under section 56 of the Act is made to the Federal Minister of Health. Section 56 allows the Federal Minister of Health to exempt persons or controlled substances if “the exemption is necessary for a medical or scientific purpose or is otherwise in the public interest” (Health Canada).
In recent years Health Canada has endeavored to increase access to psychedelic medicine for patients facing mental health challenges, including providing select approvals for exemption under Section 56 of the CDSA. On August 4, 2020, Patty Hadju, Canada’s Federal Minister of Health granted the first legal exemptions from the CDSA under section 56(1), on compassionate grounds, to four Canadians with incurable cancer to receive psilocybin therapy to treat their anxiety.
Bluejay’s wholly owned subsidiary, GreenLeaf Medical Clinic (EST 2011), was one of the first specialized medical cannabis clinics in Canada and continues to assess patients for the appropriateness of medical cannabis into Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The management team has worked closely with Health Canada, developing a strong understanding for compliance. They have also led educators in cannabinoid therapy and have worked with thousands of patients, doctors and cultivators. Bluejay intends to be one of the first clinics to have its patients granted the section 56(1) exemption as it has been at the forefront of the progressive health movement for years.
Core One is focused on advancing the use of psychedelics as alternative modalities to treating mental health afflictions, and part of this advancement is supporting and assisting patients in gaining access to such alternatives through the Company’s various Canadian-based medical and research clinics.
“With a growing roster of clinics under our umbrella, Core One continues to execute on its long-term goal of developing an internal patient base for its biosythensized psilocybin and psychedelic treatments. Submitting the application for a section 56(1) exemption is the next step in allowing our patients access to these varieties of treatments, and as one of the first companies to do so, we will be positioned as a leader in the adoption of exemptions for patients. This scalable business model has untapped potential as patients begin to receive exemptions for mental health issues ranging from depression to addiction,” stated Joel Shacker CEO of the Company.
HEXO Corp (
TSX: HEXO
) (
NYSE: HEXO
)
announced today
it has applied to transfer its U.S. stock exchange listing from the New York Stock Exchange to the Nasdaq. While this transfer remains subject to the approval of the Nasdaq, the Company expects the transfer to occur effective August 23, 2021 after market close. Common shares of HEXO are expected to begin trading as a Nasdaq-listed security on August 24, 2021, with the shares continuing to trade under the symbol “HEXO”.
“Transferring our U.S. listing to Nasdaq allows us to generate shareholder value through greater cost savings on our path towards profitability, while joining our peers on a leading global exchange,” said HEXO CEO and co-founder Sebastien St-Louis. “We are grateful for the partnership and support that the New York Stock Exchange has provided to us, allowing us to be one of the first publicly traded cannabis companies in the US.”
Current retail and institutional investor shares will automatically be transferred over to Nasdaq and current shareholders are not required to take any action. The last day of trading of the Company’s common stock on NYSE is expected to be August 23, 2021.
Flora Growth Corp. (
NASDAQ: FLGC
)
announced
the availability of a broadcast titled, “Colombia Challenges Canadian Cannabis Dominance.”
To hear the AudioPressRelease, please visit:
The NetworkNewsAudio News Podcast
To view the full editorial, please visit:
https://nnw.fm/p1UWI
Near-perfect growing conditions, skilled labor and friendly regulations have underscored Colombia’s emergence in the legal cannabis space since the country first allowed the production of medical cannabis just over five years ago. However, until now, dried cannabis flower, or buds, could only be processed for export as a medicinal oil or extract for fear that flowers would find their way to the black market. The new law puts Colombia “at the forefront in terms of regulatory competitiveness,” according to President Duque, adding that his country will now participate in new markets, including food, beverages, cosmetics, and textiles, in addition to pharmaceuticals. . .
These circumstances may play right into the hands of Flora Growth Corp., as well as other Colombian licensed producers which have focused on cannabis cultivation and processing operations in Colombia to supply international markets. The new decree could prove to be a bonanza for established licensed producers, especially when considering the extremely low production costs and that dried cannabis flower represents the majority of sales in countries with mature markets, such as the United States, Germany, United Kingdom, and Australia.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at
https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit:
https://www.investorideas.com/Audio/
.
The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our
list of top stock trading apps
including Robinhood, Acorn, Stash and others.
About Investorideas.com – News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns:
Crypto Corner
,
Play by Play
sports and stock news,
Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
,
Cleantech and Climate Change
,
Exploring Mining
,
Betting on Gaming Stocks Podcast
and the
AI Eye Podcast
.
Disclaimer/Disclosure:
Investorideas.com
is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://www.instagram.com/investorideas_potcast/
Download our
Mobile App
for iPhone and Android
Contact Investorideas.com
800-665-0411
